Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert MTB/RIF in Zimbabwe

A retrospective cohort study

Abstract

Assess linkages between diagnosis and treatment for these patients in Harare and Manicaland provinces in 2014

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Charambira, K.; Ade, S.; Harries, A. D.; Ncube, R. T.; Zishiri, C.; Sandy, C.; Mutunzi, H.; Takarinda, K.; Owiti, P. Mafaune, P. Chonzi, P. Public Health Action, Volume 6, Number 2, 21 June 2016, pp. 122-128(7) Publisher: International Union Against Tuberculosis and Lung Disease DOI: https://doi.org/10.5588/pha.16.0005

Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert MTB/RIF in Zimbabwe

Updates to this page

Published 1 June 2016